covid pfizer - Search News

Order byBest matchMost fresh

FDA, COVID and Vaccine

FDA expands COVID vaccine warning about possible side effect

The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.

· 3h

InnovationRx: FDA Will Limit Covid-19 Vaccines To Those Over 65 Or At High Risk

· 19m

FDA Announces Major Overhaul of COVID-19 Vaccine Strategy

· 7h

The FDA’s new COVID-19 vaccine policy, explained

The FDA announced a new COVID-19 vaccine policy yesterday limiting access to adults ages 65 and over and others at high risk, and raising questions about who will be able to get one this fall.

· 17h

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

· 1d

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

· 3h

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

Public trust in vaccination has declined, potentially impacting other vital immunization programs.

· 1d

New federal rules for COVID boosters could delay shots for healthy adults, kids

· 1d

FDA sets new COVID booster guidelines for healthy adults under 65

5hon MSN

Biden officials knew about, downplayed risks from COVID-19 vaccines, Senate report claims

Top health officials were aware of and actively took steps to “delay warning the public” for months in 2021 about the potential risks of patients suffering from heart-related

18hon MSN

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

6don MSN

New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel

A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations provided by a rival drugmaker.

Pfizer scientist claimed COVID vax results being delayed until after 2020 election ‘wasn’t a coincidence’: House GOP panel

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr. Philip Dormitzer, may have “conspired to withhold public

AARP1d

Third COVID Vaccine Gets Approved for Adults 65 and Over

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.

Pfizer: Better To Face The Harsh Reality Than Continue Waiting

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click to find out why PFE stock is a Hold.

Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug

Pfizer has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc for the development, manufacturing and commercialization of a drug undergoing trials for treatment of certain types of cancer and tumours,